Furthermore, significantly higher concentrations of ATG5 were identified in the kidneys of the CIS-treated Gal-3 KO mice compared to the CIS-treated Gal-3 wild-type mice, with statistical significance (p < 0.001) (Figure 10E). The gene discussed is ATG5; the disease is in situ carcinoma.